AUA: Male Urethral Stricture (2016): Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 68: | Line 68: | ||
* '''Options (4):''' | * '''Options (4):''' | ||
*# '''Uroflowmetry''' | *# '''<span style="color:#ff0000">Uroflowmetry</span>''' | ||
*# '''Post-void residual''' | *# '''<span style="color:#ff0000">Post-void residual</span>''' | ||
*# '''Patient reported measures''' | *# '''<span style="color:#ff0000">Patient reported measures</span>''' | ||
*#'''Biopsy''' | *#'''<span style="color:#ff0000">Biopsy</span>''' | ||
==== Biopsy ==== | ==== Biopsy ==== | ||
*'''Indications''' | *'''Indications''' | ||
**'''Must be performed: | **'''<span style="color:#ff0000">Must be performed: urethral cancer is suspected</span>''' | ||
**'''May be performed: suspected lichen sclerosis''' | **'''<span style="color:#ff0000">May be performed: suspected lichen sclerosis</span>''' | ||
***'''May have a higher association with urethral cancer''' | ***'''May have a higher association with urethral cancer''' | ||
**** The rate of squamous cell carcinoma in male patients with LS has been reported to be 2-9% thus further indicating the need for biopsy in selected cases both to confirm the diagnosis as well as to exclude malignant or premalignant changes. | **** The rate of squamous cell carcinoma in male patients with LS has been reported to be 2-9% thus further indicating the need for biopsy in selected cases both to confirm the diagnosis as well as to exclude malignant or premalignant changes. | ||